The nNGM (national Network Genomic Medicine lung cancer) demands the detection of defined areas including variant hot spots in 26 Genes (ALK, BRAF, CTNNB1, EGFR, ERBB2, FGFR1, FGFR2, FGFR3, FGFR4, HRAS, IDH1, IDH2, KEAP1, KRAS, MAP2K1, MET, NRAS, NTRK1, NTRK2, NTRK3, PIK3CA, PTEN, RET, ROS1, STK11, TP53). Here, MET is linked to lung cancer.